Nektar Therapeutics (BMV:NKTR)
Mexico
· Delayed Price · Currency is MXN 1,030.00
-105.00 (-9.25%)
At close: Nov 6, 2025
Nektar Therapeutics Revenue
Nektar Therapeutics had revenue of $11.79M USD in the quarter ending September 30, 2025, a decrease of -51.13%. This brings the company's revenue in the last twelve months to $62.60M, down -32.79% year-over-year. In the year 2024, Nektar Therapeutics had annual revenue of $98.43M with 9.22% growth.
Revenue (ttm)
$62.60M
Revenue Growth
-32.79%
P/S Ratio
18.34
Revenue / Employee
$1.03M
Employees
61
Market Cap
21.06B MXN
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 98.43M | 8.31M | 9.22% |
| Dec 31, 2023 | 90.12M | -1.93M | -2.10% |
| Dec 31, 2022 | 92.06M | -9.85M | -9.67% |
| Dec 31, 2021 | 101.91M | -51.01M | -33.36% |
| Dec 31, 2020 | 152.92M | 38.30M | 33.41% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wal-Mart de México | 1,002.47B |
| Grupo Financiero Banorte | 134.72B |
| Arca Continental | 250.90B |
| Industrias Peñoles | 142.01B |
| GMéxico Transportes | 64.06B |
| FIBRA Prologis | 13.58B |
| Promotora y Operadora de Infraestructura, S. A. B. de C. V. | 19.54B |
| Fibra UNO | 30.53B |